GNPX Insider Trading Activity and SEC Form 4 Filings
GNPX insider trading summary
Over the past 12 months, insiders at Genprex, Inc. (GNPX) reported 2 sales worth $22 by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $22.
Latest GNPX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 14, 2026 | Brent M Longnecker | Director | Sell | $12 (10 @ $1.23) |
| Apr 14, 2026 | Brent M Longnecker | Director | Sell | $10 (8 @ $1.23) |
| Apr 21, 2023 | Catherine M Vaczy | EVP GC Chief Strategy Officer | Buy | $21K (20,000 @ $1.07) |
| Apr 21, 2023 | John Rodney Varner | Chairman, President and CEO | Buy | $20K (19,000 @ $1.05) |
| Apr 5, 2021 | Brent M Longnecker | Director | Buy | $62K (15,000 @ $4.15) |
| Sep 5, 2019 | John Rodney Varner | Chief Executive Officer | Buy | $2K (1,800 @ $0.89) |
| Jul 30, 2018 | Julien L Pham | President & COO | Buy | $2K (500 @ $3.40) |
| Mar 29, 2018 | Jack A Roth | 10% Owner | Buy | $200K (40,000 @ $5.00) |
| Mar 29, 2018 | Christy M. Nance | 10% Owner | Buy | $250K (50,000 @ $5.00) |
| Mar 29, 2018 | John Rodney Varner | Chief Executive Officer | Buy | $50K (10,000 @ $5.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.